Enter 0 (No) or 1 (Yes) for each item.
Detailed Guide Coming Soon
We're working on a comprehensive educational guide for the Columbia Suicide Severity Rating in your language. The content below is shown in English.
What is Columbia Suicide Severity Rating?
▾
The Columbia Suicide Severity Rating Scale (C-SSRS) is the gold-standard risk-management and clinical triage tool used globally to quantify suicidal ideation and behavior. Developed in 2007 by Dr. Kelly Posner and researchers at Columbia University, the University of Pennsylvania, and the University of Pittsburgh, the scale was designed to replace subjective clinical guesswork with a highly structured, objective assessment protocol. For healthcare executives, clinical trial sponsors, and risk managers, the C-SSRS serves as an essential compliance and safety instrument that standardizes how organizations identify, track, and manage acute psychiatric risk. From an operational standpoint, the C-SSRS is unique because it explicitly decouples suicidal ideation (the cognitive state of wishing to die or planning an act) from suicidal behavior (the physical actions taken toward self-harm). This distinction is critical for efficient resource allocation. By rating ideation on a strict 5-point hierarchical scale and behavior across four distinct categories, the tool prevents both the underestimation of risk and the costly over-allocation of emergency resources for low-risk, chronic passive cases. It provides a standardized language that bridges the gap between frontline clinical staff, emergency departments, and corporate risk officers. The scale's rigorous design has led to its universal adoption by regulatory and administrative bodies worldwide. It is mandated by the U.S. Food and Drug Administration (FDA) for safety monitoring in all clinical trials involving central nervous system active drugs, recommended by the Joint Commission for healthcare organization accreditation, and utilized across the Department of Defense and Veterans Affairs. By implementing this calculator, healthcare organizations, clinical research organizations (CROs), and corporate wellness departments can establish a defensible, audit-ready clinical decision support pathway that minimizes organizational liability while maximizing patient safety.
Calkulon makes complex calculations simple — built for students and everyday problem-solvers.
Формула
▾
C-SSRS Risk Stratification and Scoring Model:
1. Suicidal Ideation Severity Score (SI_sev):
- Level 0: No active or passive suicidal ideation
- Level 1: Passive wish to be dead (desire to sleep and not wake up)
- Level 2: Non-specific active suicidal thoughts (no method, plan, or intent)
- Level 3: Active suicidal ideation with methods (but no intent or plan)
- Level 4: Active suicidal ideation with active intent (but no specific plan)
- Level 5: Active suicidal ideation with a highly specific plan and intent
2. Suicidal Ideation Intensity Score (SI_int) - Calculated only for the highest endorsed severity level:
Intensity Score = Frequency Rating (1-5) + Duration Rating (1-5) + Controllability Rating (1-5) + Deterrents Rating (1-5) + Reasons Rating (1-5)
- Range: 5 (lowest intensity) to 25 (highest intensity)
3. Suicidal Behavior Classification (SB_type):
- Actual Attempt (self-injurious act with some intent to die)
- Interrupted Attempt (stopped by external force or circumstance prior to harm)
- Aborted Attempt (stopped by the individual's own volition prior to harm)
- Preparatory Acts or Behaviors (e.g., buying a firearm, stockpiling medication, writing a will)
4. Lethality Assessment for Actual Attempts:
- Medical Lethality (ML) Score: 0 (no physical damage) to 6 (death)
- Potential Lethality (PL) Score: 0 (no potential lethality) to 3 (highly lethal without immediate medical intervention)
Worked Example:
A 42-year-old corporate executive presents to an occupational health clinic during a severe depressive episode:
- Endorses wishing to be dead: Yes (Level 1)
- Endorses active thoughts of suicide: Yes (Level 2)
- Endorses thinking of a method (overdose): Yes (Level 3)
- Endorses intent to carry it out: Yes, 'I feel like I have to do it' (Level 4)
- Endorses a specific plan/date: No (Level 5 not endorsed)
Highest Ideation Severity Level = 4
Intensity Rating Calculation for Level 4:
- Frequency: Daily (Score = 4)
- Duration: 4-8 hours a day (Score = 4)
- Controllability: Hard to control (Score = 4)
- Deterrents: Family keeps them from acting (Score = 2)
- Reasons: To stop intense emotional pain (Score = 5)
SI_int = 4 + 4 + 4 + 2 + 5 = 19 out of 25
Behavioral Assessment: Patient has started stockpiling sleeping pills (Preparatory Behavior endorsed).
Risk Level Synthesis: HIGH/IMMINENT RISK. The presence of Level 4 ideation combined with high intensity (19/25) and active preparatory behavior requires immediate clinical intervention, secure transport to an emergency facility, and continuous observation.Variable Legend
▾
| Symbol | Ime | Јединица | Опис |
|---|---|---|---|
| SI_sev | Suicidal Ideation Severity | ordinal (0-5) | The highest level of cognitive suicidal intent endorsed on the 5-point hierarchical scale, spanning from passive death wishes to structured plans. |
| SI_int | Suicidal Ideation Intensity | integer (5-25) | The aggregate score of five cognitive dimensions assessing the persistence, controllability, and driving factors of the highest endorsed ideation. |
| SB_type | Suicidal Behavior Type | category | Categorization of physical self-harm actions, identifying actual, aborted, or interrupted attempts, as well as preparatory behaviors. |
| ML | Medical Lethality | ordinal (0-6) | The objective physical damage resulting from an actual self-harm attempt, ranging from zero injury to a fatal outcome. |
| PL | Potential Lethality | ordinal (0-3) | An estimation of what the physical consequences of an attempt would have been in the absence of rapid medical intervention or rescue. |
| T_frame | Assessment Time Frame | period | The operational window evaluated during the interview, such as lifetime, past 30 days, or the interval since the last clinical contact. |
How to Columbia Suicide Severity Rating
▾
- 1Select the Context-Specific C-SSRS Protocol: Determine which version of the C-SSRS fits your organization's workflow. Use the Lifetime/Recent version for baseline intake or clinical trial screening. Use the Since Last Visit version for longitudinal monitoring in active treatment plans. Deploy the 6-item Screener version for rapid triage in emergency departments, primary care clinics, or employee health screenings.
- 2Screen for Suicidal Ideation Severity: Administer the hierarchical ideation questions starting from the lowest severity. If the patient denies passive wishes (Level 1) and active thoughts (Level 2), the clinical protocol allows you to bypass the remaining ideation questions. If they endorse active thoughts, systematically progress through methods (Level 3), intent (Level 4), and specific plans (Level 5).
- 3Quantify Ideation Intensity: For the highest severity level endorsed, evaluate the cognitive burden across five dimensions: frequency, duration, controllability, deterrents, and underlying reasons. Score each dimension from 1 to 5 to generate an aggregate Intensity Score (5-25). Higher scores indicate a more urgent need for structured crisis intervention.
- 4Document and Classify Suicidal Behavior: Conduct a separate, independent assessment of physical actions. Classify any behaviors into actual, interrupted, or aborted attempts, or preparatory acts. Because behavior can occur in the absence of reported ideation, this step must never be skipped, even if the patient scored a Level 0 on the ideation section.
- 5Evaluate Medical and Potential Lethality: For any actual attempts, score the physical consequences on a 0-6 medical lethality scale. Additionally, rate the potential lethality (0-3) to account for scenarios where a highly lethal attempt failed to cause injury purely due to rapid medical intervention or luck.
- 6Synthesize Risk Level and Formulate Disposition: Combine the ideation severity, intensity, behavioral history, and clinical risk modifiers (such as history of past attempts or access to firearms) to categorize the patient's risk as Low, Moderate, High, or Imminent. This classification dictates the immediate operational response.
- 7Execute and Document Clinical Action Plans: Initiate risk-appropriate interventions. For low-risk patients, establish outpatient safety planning and means restriction. For high or imminent-risk patients, initiate continuous one-to-one observation, secure the environment, and arrange immediate psychiatric transfer. Ensure all steps are logged for compliance and liability protection.
Worked Examples
▾
A 51-year-old corporate accountant facing restructuring reports feeling 'so exhausted I wish I just wouldn't wake up' on Monday mornings. She denies any active thoughts of self-harm, has no behavioral history, and has strong protective factors (family, job security). The low ideation severity and minimal intensity of 6/25 indicate low risk. The recommended action is outpatient counseling, stress-management resources, and a follow-up screening in two weeks.
A patient in a clinical trial endorses thinking about running their car in a closed garage (Level 3 ideation) but explicitly states they have no intention of acting on it and no specific plan. The intensity score of 16/25 represents moderate cognitive preoccupation. Because there is no recent suicidal behavior, the risk is classified as Moderate. The clinical trial protocol requires notifying the principal investigator, implementing a safety plan, and scheduling a clinical review within 48 hours.
A patient presenting to emergency triage admits to having a specific plan to use a newly purchased firearm this weekend. They have already bought ammunition (preparatory act) and have an intensity score of 25/25, indicating complete cognitive preoccupation with no effective deterrents. This represents an Imminent Risk. The patient must be placed under continuous line-of-sight observation, all personal effects secured, and immediate transfer to an inpatient psychiatric facility initiated.
Real-World Applications
▾
Clinical Trial Safety and Regulatory Compliance: Pharmaceutical sponsors and CROs integrate the C-SSRS into clinical protocols to meet stringent FDA and EMA safety requirements. By systematically tracking treatment-emergent suicidal ideation and behavior, sponsors can distinguish between drug-induced psychiatric adverse events and baseline disease symptoms, safeguarding clinical assets and ensuring trial integrity.
Hospital System Triage and Resource Management: Major hospital networks embed the C-SSRS Screener directly into Electronic Health Record (EHR) triage workflows. This standardization allows nursing staff to rapidly identify high-risk admissions across all units, optimizing the deployment of psychiatric consult teams and reducing unnecessary, costly 1-to-1 patient watches for low-risk individuals.
Corporate Employee Assistance Programs (EAPs): Self-insured enterprises and corporate wellness providers utilize the C-SSRS Screener within occupational health and EAP programs. When employees seek help for acute stress or mental health crises, the structured protocol ensures EAP counselors can objectively measure risk, initiate defensible safety plans, and coordinate appropriate higher levels of care.
Healthcare Liability and Risk Management: Risk management departments in medical centers mandate the use of the C-SSRS to establish a standardized, legally defensible clinical pathway. Comprehensive documentation of a C-SSRS score, paired with a corresponding risk-appropriate safety plan, provides crucial protection against malpractice claims by demonstrating adherence to the accepted national standard of care.
Special Cases
▾
Managing Acute Substance Intoxication
When administering the C-SSRS to individuals under the influence of drugs or alcohol, clinicians must proceed with heightened vigilance. Intoxication frequently amplifies emotional distress and lowers behavioral inhibition, turning passive ideation into acute, impulsive action. While an intoxicated patient's self-reported intent may fluctuate as they sober up, any endorsement of Level 4 or 5 ideation during intoxication must be treated as highly acute. The assessment should be repeated once the patient is sober to establish a reliable baseline, but immediate safety protocols must not be delayed in anticipation of sobriety.
Tracking Chronic Ideation in High-Utilization Populations
In patients with severe, chronic psychiatric conditions (such as borderline personality disorder or treatment-resistant depression), passive or moderate suicidal ideation may represent a persistent baseline state rather than an acute crisis. For these populations, clinical managers should utilize the 'Since Last Visit' version of the C-SSRS. This approach allows clinical teams to monitor deviations from the patient's typical baseline. A shift from a chronic Level 2 to an active Level 4 represents a critical clinical inflection point requiring immediate intervention, whereas a stable, long-term Level 2 can often be managed through ongoing outpatient safety plans.
Cross-Cultural Implementation and Stigma
In global clinical trials or multinational corporate wellness programs, administrators must account for varying cultural attitudes toward suicide. In many regions, deep-seated social stigma or legal consequences can lead to severe underreporting of suicidal thoughts. To mitigate this risk, assessors must be trained to establish a neutral, non-judgmental environment and to ask the C-SSRS questions exactly as written, without using euphemisms. Standardizing the delivery of these questions helps normalize the process and ensures consistent, cross-border safety data.
C-SSRS Risk Levels and Recommended Clinical Response
▾
| Ideation Level | Description | Risk Classification | Recommended Action | Monitoring Frequency |
|---|---|---|---|---|
| 0 | No ideation | Baseline | Document, routine follow-up | Next scheduled visit |
| 1 | Wish to be dead | Low | Safety planning, means restriction counseling | 1-2 weeks |
| 2 | Non-specific active thoughts | Low-Moderate | Safety plan, increase treatment, follow-up | 1 week |
| 3 | Active ideation with methods, no intent | Moderate | Enhanced safety plan, urgent follow-up | 48-72 hours |
| 4 | Active ideation with some intent | High | Psychiatric evaluation, consider hospitalization | 24-48 hours or inpatient |
| 5 | Active ideation with plan and intent | Imminent | Emergency psychiatric evaluation, do not leave alone | Continuous until evaluated |
| Any + recent behavior | Ideation plus behavioral history | Elevated above ideation-only | Factor behavior history into risk formulation | Per behavior severity |
Frequently Asked Questions
▾
Is the C-SSRS the best suicide screening tool?
The C-SSRS is the most widely adopted suicide risk assessment tool globally, required by the FDA for clinical trials and adopted by the US military, VA, and many healthcare systems. Its structured format reduces clinician variability in assessing risk.
Can non-clinicians administer the C-SSRS?
Yes. The C-SSRS screener version is designed for use by anyone with brief training, including teachers, first responders, and peer counselors. The full clinical version requires clinical training.
What should I do if someone screens positive?
Follow your organization's protocol. Generally: ensure immediate safety, do not leave the person alone, remove access to lethal means, initiate a safety plan, and connect to crisis services (988 Suicide & Crisis Lifeline).
Common Mistakes to Avoid
▾
- !Treating Ideation and Behavior as a Single Linear Variable: A common and costly operational error is assuming that patients only attempt suicide if they have previously expressed high-level ideation (Levels 4 or 5). In reality, impulsive actions can occur with low-level or even denied ideation. Always assess behavior (especially preparatory acts) independently of ideation to prevent under-triaging high-risk individuals.
- !Relying Solely on the Numerical Score Without Risk Modifiers: The C-SSRS is a decision-support tool, not a replacement for clinical judgment. Failing to factor in external risk multipliers—such as a history of near-lethal past attempts, acute substance abuse, severe agitation, or recent discharge from a psychiatric facility—can lead to dangerously low risk classifications. A patient with Level 2 ideation but multiple high-risk contextual factors may require much more intensive intervention than their base score suggests.
- !Neglecting Serial Reassessments in Dynamic Environments: Suicidal risk is highly volatile and can fluctuate dramatically within a 24-hour period. Relying on an initial intake C-SSRS score throughout a multi-week hospital stay or clinical trial phase without conducting serial 'Since Last Visit' assessments is a major compliance risk. Reassessments should always be triggered by major clinical transitions, medication changes, or acute psychosocial stressors.
Pro Tip
When administering the C-SSRS, never rephrase the questions to make them sound 'softer' or less direct. Avoid substituting terms like 'hurting yourself' for 'killing yourself,' as this introduces measurement error and conflates non-suicidal self-injury with suicidal intent. Empirical research consistently demonstrates that asking direct, explicit questions about suicide does not induce suicidal thoughts; rather, it provides patients with a profound sense of relief and yields the highly accurate data necessary for effective risk management.
Did you know?
The C-SSRS transformed the economics of pharmaceutical development. Prior to its widespread adoption, clinical trials utilized inconsistent and highly subjective metrics to track psychiatric safety, which frequently led to false safety signals, delayed drug approvals, and billions of dollars in lost R&D spending. By providing a single, standardized, and FDA-endorsed metric, the C-SSRS streamlined the regulatory approval pipeline, saving sponsors immense capital while establishing a uniform global standard for patient safety.
Regional Guides
▾
United States▾
European Union▾
World Health Organization▾
Australia▾
References
- ›The Columbia Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings - Posner et al., American Journal of Psychiatry, 2011
- ›Columbia Lighthouse Project - Free C-SSRS Training and Resources
- ›FDA Guidance: Suicidal Ideation and Behavior: Prospective Assessment of Occurrence in Clinical Trials, 2012
Ratings & comments
Добијте недељне савете за математику
Придружите се КСЦОУНТ+ претплатницима који сваке недеље добијају савете за калкулатор.